EPITOX Trademark

Trademark Overview


On Thursday, April 23, 2020, a trademark application was filed for EPITOX with the United States Patent and Trademark Office. The USPTO has given the EPITOX trademark a serial number of 79287183. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by JETEMA CO., LTD.. The EPITOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating middle of the forehead wrinkles, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for treating orthopaedic purposes; pharmaceutical preparations acting on the central nervous system; analgesic preparations; medicines for dental purposes; therapeutic drugs and agents as pharmaceuticals for treatment of wrinkles; pharmaceutical preparations for treating pain; pharmaceutical products for skin care for medical purposes, namely, botulinum toxin, botulinum toxin-hemagglutinin complex, botulinum toxin fragments and other derivatives; pharmaceutical preparations for treating neurological diseases, namely, botulinum toxin, botulinum toxin-hemagglutinin complex, botulinum toxin fragments and other derivatives; pharmaceutical preparation for skin care; medicated skin preparation for use in treating wrinkles; pharmaceutical preparations for treatment of respiratory organ disorder; preparations for the tr...
epitox

General Information


Serial Number79287183
Word MarkEPITOX
Filing DateThursday, April 23, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6405698
Registration DateTuesday, July 6, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating middle of the forehead wrinkles, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for treating orthopaedic purposes; pharmaceutical preparations acting on the central nervous system; analgesic preparations; medicines for dental purposes; therapeutic drugs and agents as pharmaceuticals for treatment of wrinkles; pharmaceutical preparations for treating pain; pharmaceutical products for skin care for medical purposes, namely, botulinum toxin, botulinum toxin-hemagglutinin complex, botulinum toxin fragments and other derivatives; pharmaceutical preparations for treating neurological diseases, namely, botulinum toxin, botulinum toxin-hemagglutinin complex, botulinum toxin fragments and other derivatives; pharmaceutical preparation for skin care; medicated skin preparation for use in treating wrinkles; pharmaceutical preparations for treatment of respiratory organ disorder; preparations for the treatment of burns; preparations for the treatment of scar; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating muscle disorders; pharmaceutical agents affecting metabolism; bacterial poisons; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for treating middle of the forehead wrinkles; pharmaceutical preparations for use in the cosmetic field, namely, medicated cosmetics; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; botulinum toxin for medical use for use in the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for the treatment of urogenital organ disorders; pharmaceutical preparations for plastic surgery; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparations for house pets for injuries and pain, namely, pharmaceuticals containing botulinum toxin; cardiovascular agents for medical purposes; pharmaceutical preparations for treating neurological disorders; ophthalmic preparations; pharmaceutical preparations for treating facial cramps; allergy medications; chemical preparations for pharmaceutical purposes, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; chemico-pharmaceutical preparations, namely, for neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; pharmaceutical preparations for treating facial wrinkles; pharmaceutical agents for epidermis; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain; medicines for human purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle disorders, nerve disorders, headaches, wrinkles, sports injuries, spasms, tremors and pain
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJETEMA CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR

Party NameJETEMA CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR

Party NameJETEMA CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Friday, October 6, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 28, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 4, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 4, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 6, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Sunday, April 18, 2021NOTIFICATION PROCESSED BY IB
Wednesday, March 31, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 31, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 18, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, March 18, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 18, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, March 18, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, February 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, January 2, 2021NEW REPRESENTATIVE AT IB RECEIVED
Sunday, September 27, 2020REFUSAL PROCESSED BY IB
Saturday, September 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 24, 2020REFUSAL PROCESSED BY MPU
Friday, July 17, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 16, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 15, 2020ASSIGNED TO EXAMINER
Tuesday, June 16, 2020APPLICATION FILING RECEIPT MAILED
Friday, June 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 11, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB